GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chempartner Pharmatech Co Ltd (SZSE:300149) » Definitions » YoY EBITDA Growth

Chempartner Pharmatech Co (SZSE:300149) YoY EBITDA Growth : 126.92% (As of Mar. 2025)


View and export this data going back to 2010. Start your Free Trial

What is Chempartner Pharmatech Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Chempartner Pharmatech Co's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was 126.92%.

Chempartner Pharmatech Co's EBITDA per Share for the three months ended in Mar. 2025 was ¥0.01.


Chempartner Pharmatech Co YoY EBITDA Growth Historical Data

The historical data trend for Chempartner Pharmatech Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chempartner Pharmatech Co YoY EBITDA Growth Chart

Chempartner Pharmatech Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.39 -125.21 1,223.73 -177.58 90.47

Chempartner Pharmatech Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.96 -360.00 133.33 85.58 126.92

Chempartner Pharmatech Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Chempartner Pharmatech Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(-0.147--1.543)/ | -1.543 |
=90.47 %

Chempartner Pharmatech Co's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

YoY EBITDA Growth (Q: Mar. 2025 )
=(EBITDA per Share (Q: Mar. 2025 )-EBITDA per Share (Q: Mar. 2024 )) / | EBITDA per Share (Q: Mar. 2024 )) |
=(0.014--0.052)/ | -0.052 |
=126.92 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chempartner Pharmatech Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Chempartner Pharmatech Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Chempartner Pharmatech Co Business Description

Traded in Other Exchanges
N/A
Address
No. 268 Dongfeng Middle Road, 28th Floor, Exchange Square, Yuexiu District, Guangzhou City, Guangdong, CHN, 529081
Chempartner Pharmatech Co Ltd is engaged in the research, development, production, and operation of prebiotics, micro-ecological medical, and biopharmaceuticals.
Executives
Qi Jia Hui Supervisors
Yang Xin Qiu Executives
Ceng Xian Jing Director
Xie Yong Kui Director
Zhou Xin Ping Director
Wang Cong Wei Director

Chempartner Pharmatech Co Headlines

No Headlines